|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 295/205 | (2006.01) |
| C07D 213/75 | (2006.01) |
| (11) | Number of the document | 3645518 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18743314.9 |
| Date of filing the European patent application | 2018-06-29 | |
| (97) | Date of publication of the European application | 2020-05-06 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-19 |
| (46) | Date of publication of the claims translation | 2021-10-11 |
| (86) | Number | PCT/US2018/040176 |
| Date | 2018-06-29 |
| (87) | Number | WO 2019/006231 |
| Date | 2019-01-03 |
| (30) | Number | Date | Country code |
| 201762527174 P | 2017-06-30 | US | |
| 201862664363 P | 2018-04-30 | US |
| (72) |
CAILLE, Sebastien, US
QUASDORF, Kyle, US
ROOSEN, Philipp, US
SHI, Xianqing, US
COSBIE, Andrew, US
WANG, Fang, US
WU, Zufan, US
NEERGUNDA, Archana, US
QUAN, Bin, Peter, US
GUAN, Lianxiu, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Omekamitivo mekarbilo sintezė |
| SYNTHESIS OF OMECAMTIV MECARBIL |
| Payment date | Validity (years) | Amount | |
| 2025-05-22 | 8 | 185.00 EUR |
| 2026-06-29 |